Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $225.62 | 11 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $108.03 | 6 | $0 (2022) |
| Allergan Inc. | $55.88 | 3 | $0 (2017) |
| Bard Peripheral Vascular, Inc. | $47.60 | 1 | $0 (2020) |
| LEICA MICROSYSTEMS INC. | $14.11 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $108.03 | 6 | ABBVIE INC. ($108.03) |
| 2020 | $61.71 | 2 | Bard Peripheral Vascular, Inc. ($47.60) |
| 2017 | $55.88 | 3 | Allergan Inc. ($55.88) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: NEUROSCIENCE | ||||||
| 07/25/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: NEUROSCIENCE | ||||||
| 07/14/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.21 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2020 | Bard Peripheral Vascular, Inc. | — | Food and Beverage | In-kind items and services | $47.60 | General |
| Category: BD Interventional - Peripheral Intervention | ||||||
| 08/20/2020 | LEICA MICROSYSTEMS INC. | N/A (Device) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: CANCER DIAGNOSTICS | ||||||
| 06/27/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: NEUROSCIENCE | ||||||
| 03/31/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/07/2017 | Allergan Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,276 | 2,336 | $591,795 | $156,847 |
| 2022 | 20 | 1,081 | 1,162 | $291,883 | $66,107 |
| 2021 | 17 | 1,000 | 1,035 | $246,376 | $67,061 |
| 2020 | 12 | 2,485 | 2,510 | $663,636 | $203,046 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 535 | 535 | $264,173 | $77,336 | 29.3% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 426 | 426 | $51,120 | $24,726 | 48.4% |
| 77067 | Screening mammography | Facility | 2023 | 226 | 226 | $23,046 | $8,913 | 38.7% |
| 77063 | Screening 3d breast mammography | Facility | 2023 | 205 | 205 | $7,175 | $6,421 | 89.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 22 | 22 | $25,872 | $3,387 | 13.1% |
| 77065 | Diagnostic mammography of 1 breast | Office | 2023 | 29 | 32 | $14,718 | $3,218 | 21.9% |
| 77066 | Diagnostic mammography of both breasts | Office | 2023 | 22 | 22 | $12,491 | $3,006 | 24.1% |
| 76642 | Limited ultrasound scan of 1 breast | Office | 2023 | 34 | 37 | $19,714 | $2,979 | 15.1% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 34 | 34 | $28,266 | $2,800 | 9.9% |
| 76700 | Complete ultrasound scan of abdomen | Office | 2023 | 22 | 22 | $18,931 | $2,163 | 11.4% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 20 | 20 | $15,890 | $1,840 | 11.6% |
| 76706 | Ultrasound scan of abdominal aorta | Office | 2023 | 14 | 14 | $6,962 | $1,640 | 23.6% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Office | 2023 | 20 | 20 | $17,421 | $1,534 | 8.8% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 171 | 199 | $4,975 | $1,512 | 30.4% |
| 77049 | Mri scan of both breasts | Facility | 2023 | 15 | 16 | $4,896 | $1,456 | 29.7% |
| 76642 | Limited ultrasound scan of 1 breast | Facility | 2023 | 55 | 56 | $5,269 | $1,429 | 27.1% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 13 | 13 | $10,536 | $1,349 | 12.8% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 13 | 13 | $10,533 | $1,258 | 11.9% |
| 77065 | Diagnostic mammography of 1 breast | Facility | 2023 | 40 | 42 | $4,536 | $1,203 | 26.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 39 | 39 | $15,139 | $1,198 | 7.9% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Office | 2023 | 26 | 27 | $3,240 | $1,116 | 34.5% |
| 77066 | Diagnostic mammography of both breasts | Facility | 2023 | 33 | 33 | $4,389 | $1,106 | 25.2% |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | Facility | 2023 | 40 | 40 | $1,400 | $826.65 | 59.0% |
| 76641 | Complete ultrasound scan of 1 breast | Facility | 2023 | 22 | 22 | $3,237 | $711.03 | 22.0% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2023 | 33 | 35 | $2,065 | $582.08 | 28.2% |
About Linda Chen
Linda Chen is a Diagnostic Radiology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/31/2013. The National Provider Identifier (NPI) number assigned to this provider is 1346583127.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Linda Chen has received a total of $225.62 in payments from pharmaceutical and medical device companies, with $108.03 received in 2022. These payments were reported across 11 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($225.62).
As a Medicare-enrolled provider, Chen has provided services to 6,842 Medicare beneficiaries, totaling 7,043 services with total Medicare billing of $493,061. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Seattle, WA
- Active Since 03/31/2013
- Last Updated 07/08/2021
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1346583127
Products in Payments
- QULIPTA (Drug) $108.03
- LINZESS (Drug) $37.09
- VRAYLAR (Drug) $18.79
- N/A (Device) $14.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Seattle
Guy Johnson
Diagnostic Radiology — Payments: $194,038
Dr. Dushyant Sahani, Md, MD
Diagnostic Radiology — Payments: $152,032
Eniola Oluyemi, Md, MD
Diagnostic Radiology — Payments: $146,823
Marissa Lawson, Md, MD
Diagnostic Radiology — Payments: $141,917
Nathan Cross, Md, MD
Diagnostic Radiology — Payments: $141,035
Dr. Kathryn Lowry, M.d, M.D
Diagnostic Radiology — Payments: $80,445